MapLight Therapeutics, Inc. (MPLT) Stock Analysis

Free AI-powered analysis and research for MapLight Therapeutics, Inc. stock

Sector: Healthcare

Analyze MapLight Therapeutics, Inc. (MPLT) Stock

MapLight Therapeutics, Inc. (MPLT) is a leading company in the Healthcare sector. Use StockIQ's free analysis tool to get comprehensive insights into MPLT stock performance, technical indicators, and AI-powered trading recommendations.

Get instant AI-powered analysis including technical indicators, fundamental analysis, risk assessment, and trading insights for MapLight Therapeutics, Inc. stock.

Analyze MPLT Now →

📰 Latest Update

MPLT Stock Plunges 73% — Wipes Out Over $1B In Market Cap After Trial Miss On Once-Daily Dose

Mon, July 27, 2026 at 11:08 PM UTC 3 min read

MPLT's stock plummeted 73%, resulting in a loss of over $1 billion in market capitalization, following disappointing trial results for its once-daily dosing regimen. This significant decline raises concerns for investors regarding the company's future prospects and potential revenue streams. The trial miss may hinder MPLT's ability to compete effectively in the market, prompting investors to reassess their positions in light of the increased uncertainty surrounding the company's product pipeline.

Read full article →